Vaping Adverse Lung and Heart Events Cohort
Launched by LAVAL UNIVERSITY · Feb 26, 2024
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
The Vaping Adverse Lung and Heart Events Cohort is a clinical trial that aims to understand how vaping, or using electronic cigarettes, affects the lungs and heart of adult users. The study is looking for participants who are at least 18 years old, use electronic cigarettes daily, and have not had a respiratory infection in the four weeks before their visit. Women who are pregnant or breastfeeding cannot participate in this study.
Participants will visit the study site every six months for five years, where they will undergo various assessments to help researchers track any changes in lung and heart health over time. This study is currently recruiting participants, so if you or someone you know fits the eligibility criteria, this could be a great opportunity to contribute to important research on the effects of vaping.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18 years or older
- • Daily electronic cigarette user
- • No respiratory infection in the 4 weeks before a visit
- Exclusion Criteria:
- • Women who are pregnant or breast-feeding.
About Laval University
Laval University is a prestigious research institution located in Quebec, Canada, renowned for its commitment to advancing knowledge and innovation in various fields, including health sciences. The university actively engages in clinical trials aimed at exploring new therapeutic interventions and improving patient outcomes. With a strong emphasis on ethical standards and rigorous scientific methodologies, Laval University collaborates with multidisciplinary teams of researchers, healthcare professionals, and industry partners to conduct high-quality clinical research. Its state-of-the-art facilities and dedication to fostering a culture of inquiry position Laval University as a leader in clinical research, contributing significantly to the understanding and treatment of diverse medical conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Québec, , Canada
Patients applied
Trial Officials
Mathieu C Morissette, PhD
Principal Investigator
Laval University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported